Clinical Trial Update: A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 study in healthy male volunteers evaluating a new drug intended for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Unnamed investigational drug

Snippet

Sponsor: Vernalis (R&D) Ltd | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED